To further support the needs of bunion patients, Treace has introduced its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities. The Company ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

1 Day TMCI -1.50% DJIA -0.32% Russell 2K -0.30% Health Care/Life Sciences -0.52% ...

Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts ... midfoot deformities through its flagship Lapiplasty ® and Adductoplasty ® Procedures, today announced that John T.

1 Day TMCI -4.19% DJIA 0.52% Russell 2K 1.13% Health Care/Life Sciences 0.39% ...

To further support the needs of bunion patients, Treace has introduced its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities. The ...

Treace, CEO, Founder and Board Member of Treace. “Driven by our active pipeline of differentiated technologies, we are excited to enter 2025 with multiple innovative product launches ...

Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Treace Medical Concepts (TMCI – Research Report) yesterday. The company’s shares closed yesterday at $8.36. Discover outperforming ...